108.31 0.07 (0.06%)
Prices By Xignite, in USD |   Market Closed
Trade
Sell
S
108.31
Buy
B
108.53

Overview

Prev Close108.24
Day's Range107.18 - 108.43
52 Week Range58.54 - 110.59
Average Volume (3m)7.37M
1-Year Return59.40%
Beta0.8343
Market Cap77.04B
P/E Ratio13.32
Revenue16.9B
EPS8.1272
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Biotechnology
CEO Mark J. Alles
Employees 8,852

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2018, Celgene Corp's revenues increased 19.18% to 15.28B. Net income increased 37.62% to 4.05B. Net assets increased 119.77% to 15.21B and EPS increased from 3.64 to 5.51.
CELG's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
93.60%
Net Profit Margin
22.37%
Operating Margin
47.90%
Return On Investment
12.39%
12/18
03/19
06/19
09/19
Total Revenue
4.04B
4B
4.4B
4.5B
Gross Profit
3.87B
3.75B
4.25B
4.23B
Operating Income
1.75B
1.76B
N/A
2.28B
Net Income
1.07B
1.55B
1.57B
1.69B